Macron Tries To ‘Cut Demand’ By Criticizing Oxford / AstraZeneca Shot, Says Vaccine Scientist – POLITICO
Novavax stock up more than 20% after COVID-19 vaccine trial shows nearly 90% efficacy in UK, but less against new South African variant